BRD2 and cancer: The BET family of proteins (Brd2, 3, 4, and T) are of significant clinical interest due to their role in cell cycle regulation, epigenetic sensing, and a range of cancers from oral, breast, prostate, lung, colon, to myeloid leukemia.